• Freshpet, Inc. Reports Third Quarter 2024 Financial Results

    Источник: Nasdaq GlobeNewswire / 04 ноя 2024 05:30:00   America/Chicago

    25th Consecutive Quarter of >25% Year on Year Net Sales Growth 
    Strong Operating Performance Drove Significant Margin Expansion & Cash Generation 
    Company Raises 2024 Net Sales and Adjusted EBITDA Guidance

    BEDMINSTER, N.J., Nov. 04, 2024 (GLOBE NEWSWIRE) -- Freshpet, Inc. (“Freshpet” or the “Company”) (Nasdaq: FRPT) today reported financial results for its third quarter ended September 30, 2024.

    Third Quarter 2024 Financial Highlights Compared to Prior Year Period

    • Net sales of $253.4 million, an increase of 26.3%.
    • Net income of $11.9 million, compared to the prior year period net loss of $7.2 million.
    • Gross margin of 40.4%, compared to the prior year period of 33.0%.
    • Adjusted Gross Margin of 46.5%, compared to the prior year period of 40.2%.1
    • Adjusted EBITDA of $43.5 million, compared to the prior year period of $23.2 million.1
    • For the first nine months of 2024, net cash provided by operating activities of $103.9 million, compared to the prior year period of $39.0 million.

    "Our third quarter results demonstrate the strength and consistency of both net sales and profitability growth we have been striving to deliver. We delivered our 25th consecutive quarter of >25% year on year net sales growth and matched that with a very strong operating performance. This further strengthens our confidence in our ability to meet or exceed our 2027 goals,” commented Billy Cyr, Freshpet’s Chief Executive Officer. “We are raising our net sales and Adjusted EBITDA guidance for 2024 to reflect this continued strong performance and our confidence in our ability to finish the year strongly and, as a result, create significant shareholder value in a way that serves pets, people, and the planet."

    Third Quarter 2024

    Net sales increased 26.3% to $253.4 million for the third quarter of 2024 compared to $200.6 million for the prior year period. The increase in net sales was primarily driven by volume gains of 26.1%.

    Gross profit was $102.2 million, or 40.4% as a percentage of net sales, for the third quarter of 2024, compared to $66.3 million, or 33.0% as a percentage of net sales, for the prior year period. The increase in reported gross profit as a percentage of net sales was primarily due to lower input costs and reduced quality costs. For the third quarter of 2024, Adjusted Gross Profit was $117.7 million, or 46.5% as a percentage of net sales, compared to $80.6 million, or 40.2% as a percentage of net sales, for the prior year period.1

    Selling, general and administrative expenses (“SG&A”) were $90.3 million for the third quarter of 2024 compared to $73.4 million for the prior year period. SG&A as a percentage of net sales decreased by 90 basis points to 35.7% for the third quarter of 2024 compared to 36.6% for the prior year period, primarily due to reduced logistics costs as a percentage of net sales and the non-recurring charges in the prior year, partially offset by increased media as a percentage of net sales, higher share-based compensation and increased variable compensation accrual. Adjusted SG&A for the third quarter of 2024 was $74.2 million, or 29.3% as a percentage of net sales, compared to $57.4 million, or 28.6% as a percentage of net sales, for the prior year period.1

    Net income was $11.9 million for the third quarter of 2024 compared to net loss of $7.2 million for the prior year period. The increase in net income was due to contribution from higher sales, improved gross margin, and reduced logistics costs as a percentage of net sales, partially offset by increased SG&A expenses.

    Adjusted Gross Margin, Adjusted Gross Profit, Adjusted SG&A and Adjusted EBITDA are non-GAAP financial measures. See "Non-GAAP Measures" for how the Company defines these measures and the financial tables that accompany this release for reconciliations of these measures to the closest comparable GAAP measures.

    Adjusted EBITDA was $43.5 million for the third quarter of 2024 compared to $23.2 million for the prior year period.1 The increase in Adjusted EBITDA was a result of increased Adjusted Gross Profit, partially offset by higher Adjusted SG&A expenses.

    First Nine Months of 2024

    Net sales increased 29.2% to $712.5 million for the first nine months of 2024 compared to $551.5 million for the prior year period. The increase in net sales was primarily driven by volume gains of 28.2%.

    Gross profit was $284.4 million, or 39.9% as a percentage of net sales, for the first nine months of 2024, compared to $176.3 million, or 32.0% as a percentage of net sales, for the prior year period. The increase in reported gross profit as a percentage of net sales was primarily due to lower input costs and reduced quality costs. For the first nine months of 2024, Adjusted Gross Profit was $327.2 million, or 45.9% as a percentage of net sales, compared to $218.1 million, or 39.5% as a percentage of net sales, for the prior year period.1

    Selling, general and administrative expenses (“SG&A”) were $265.7 million for the first nine months of 2024 compared to $221.6 million for the prior year period. SG&A as a percentage of net sales decreased by 290 basis points to 37.3% for the first nine months of 2024 compared to 40.2% for the prior year period, primarily due to reduced logistics costs and media as a percentage of net sales and the non-recurring charges in the prior year, partially offset by higher share-based compensation and increased variable compensation accrual. Adjusted SG&A for the first nine months of 2024 was $218.0 million, or 30.6% as a percentage of net sales, compared to $182.9 million, or 33.2% as a percentage of net sales, for the prior year period.1

    Net income was $28.8 million for the first nine months of 2024 compared to a net loss of $48.9 million for the prior year period. The improvement in net income was due to contribution from higher sales, improved gross margin, reduced logistics costs as a percentage of net sales, and gain on equity investment, partially offset by increased SG&A expenses.

    Adjusted EBITDA was $109.2 million for the first nine months of 2024, compared to $35.2 million for the prior year period.1 The increase in Adjusted EBITDA was a result of increased Adjusted Gross Profit partially offset by higher Adjusted SG&A expenses.

    Balance Sheet

    As of September 30, 2024, the Company had cash and cash equivalents of $274.6 million with $394.6 million of debt outstanding net of $7.9 million of unamortized debt issuance costs. For the nine months ended September 30, 2024, cash from operations was $103.9 million, an increase of $65.0 million compared to the prior year period.

    The Company will utilize its balance sheet to support its ongoing capital needs in connection with its long-term capacity plan.

    Outlook

    For full year 2024, the Company is updating its guidance and now expects the following:

    • Net sales of ~$975 million, an increase of ~27% from 2023, compared to at least $965 million in the previous guidance;
    • Adjusted EBITDA of at least $155 million, compared to at least $140 million in the previous guidance; and
    • Capital expenditures of ~$180 million, compared to ~$200 million in the previous guidance.

    The Company does not provide guidance for net income (loss), the U.S. GAAP measure most directly comparable to Adjusted EBITDA, and similarly cannot provide a reconciliation between its forecasted Adjusted EBITDA and net income (loss) metrics without unreasonable effort due to the unavailability of reliable estimates for certain components of net income (loss) and the respective reconciliations, including the timing of and amount of costs of goods sold and selling, general and administrative expenses. These items are not within the Company's control and may vary greatly between periods and could significantly impact future results.

    Conference Call & Earnings Presentation Webcast Information
    As previously announced, today, November 4, 2024, the Company will host a conference call beginning at 8:00 a.m. Eastern Time with members of its leadership team. The conference call webcast will be available live over the Internet through the "Investors" section of the Company's website at www.freshpet.com. To participate on the live call, listeners in North America may dial (877) 407-0792 and international listeners may dial (201) 689-8263.

    A replay of the conference call will be archived on the Company's website and telephonic playback will be available from 12:00 p.m. Eastern Time today through November 18, 2024. North American listeners may dial (844) 512-2921 and international listeners may dial (412) 317-6671; the passcode is 13749124.

    About Freshpet

    Freshpet’s mission is to improve the lives of dogs and cats through the power of fresh, real food. Freshpet foods are blends of fresh meats, vegetables and fruits farmed locally and made at our Freshpet Kitchens. We thoughtfully prepare our foods using natural ingredients, cooking them in small batches at lower temperatures to preserve the natural goodness of the ingredients. Freshpet foods and treats are kept refrigerated from the moment they are made until they arrive at Freshpet Fridges in your local market.

    Our foods are available in select grocery, mass, digital, pet specialty, and club retailers across the United States, Canada and Europe. From the care we take to source our ingredients and make our food, to the moment it reaches your home, our integrity, transparency and social responsibility are the way we like to run our business. To learn more, visit www.freshpet.com.

    Connect with Freshpet:

    https://www.facebook.com/Freshpet

    https://x.com/Freshpet

    http://instagram.com/Freshpet

    http://pinterest.com/Freshpet

    https://www.tiktok.com/@Freshpet

    https://www.youtube.com/user/freshpet400

    Forward Looking Statements

    Certain statements in this release constitute “forward-looking” statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements relating to our ability to achieve our 2027 targets, create meaningful shareholder value, and guidance with respect to 2024 net sales, Adjusted EBITDA and capital expenditures. These statements are based on management's current opinions, expectations, beliefs, plans, objectives, assumptions or projections regarding future events or future results. While Freshpet believes that its assumptions are reasonable, it is very difficult to predict the impact of known factors, and, of course, it is impossible to anticipate all factors that could affect actual results. There are several risks and uncertainties which could cause actual results, performance, and achievements to differ materially from those stated or implied by the forward-looking statements described herein, including, most prominently, the risks discussed under the heading “Risk Factors” in the Company's latest annual report on Form 10-K and its quarterly reports on Form 10-Q filed with the Securities and Exchange Commission. Such forward-looking statements are made only as of the date of this release. Freshpet undertakes no obligation to publicly update or revise any forward-looking statement because of new information, future events or otherwise, except as otherwise required by law. If we do update one or more forward-looking statements, no inference should be made that we will make additional updates with respect to those or other forward-looking statements.

    Non-GAAP Financial Measures

    Freshpet uses the following non-GAAP financial measures in its financial communications. These non-GAAP financial measures should be considered as supplements to the U.S. GAAP reported measures, should not be considered replacements for, or superior to, the U.S. GAAP measures and may not be comparable to similarly named measures used by other companies.

    • Adjusted Gross Profit
    • Adjusted Gross Profit as a percentage of net sales (Adjusted Gross Margin)
    • Adjusted SG&A Expenses
    • Adjusted SG&A Expenses as a percentage of net sales
    • EBITDA
    • Adjusted EBITDA
    • Adjusted EBITDA as a percentage of net sales

    Adjusted Gross Profit: Freshpet defines Adjusted Gross Profit as gross profit before depreciation expense, non-cash share-based compensation and loss on disposal of manufacturing equipment.

    Adjusted SG&A Expenses: Freshpet defines Adjusted SG&A as SG&A expenses before depreciation and amortization expense, non-cash share-based compensation, implementation and other costs associated with the implementation of an enterprise resource planning ("ERP") system, fees related to the capped call transactions, loss on disposal of equipment, and advisory fees related to shareholder activism defense engagement.

    EBITDA and Adjusted EBITDA: EBITDA represents net income (loss) plus interest expense net of interest income, income tax expense and depreciation and amortization expense, and Adjusted EBITDA represents EBITDA plus loss on equity method investment, gain on equity investment, non-cash share-based compensation expense, implementation and other costs associated with the implementation of an ERP system, loss on disposal of property, plant and equipment, fees related to the capped call transactions, and advisory fees related to shareholder activism defense engagement.

    Management believes that the non-GAAP financial measures are meaningful to investors because they provide a view of the Company with respect to ongoing operating results. The non-GAAP financial measures are shown as supplemental disclosures in this release because they are widely used by the investment community for analysis and comparative evaluation. They also provide additional metrics to evaluate the Company’s operations and, when considered with both the Company’s GAAP results and the reconciliation to the most comparable U.S. GAAP measures, provide a more complete understanding of the Company’s business than could be obtained absent this disclosure. The non-GAAP measures are not and should not be considered an alternative to the most comparable U.S. GAAP measures or any other figure calculated in accordance with U.S. GAAP, or as an indicator of operating performance. The Company’s calculation of the non-GAAP financial measures may differ from methods used by other companies. Management believes that the non-GAAP measures are important to an understanding of the Company's overall operating results in the periods presented. The non-GAAP financial measures are not recognized in accordance with U.S. GAAP and should not be viewed as an alternative to U.S. GAAP measures of performance.

    Investor Contact:
    Rachel Ulsh
    Rulsh@freshpet.com

    Media Contact:
    Press@freshpet.com


    FRESHPET, INC. AND SUBSIDIARIES
    CONDENSED CONSOLIDATED BALANCE SHEETS
    (Unaudited, in thousands, except per share data)
     
     September 30,
    2024
     December 31,
    2023
    ASSETS   
    CURRENT ASSETS:   
    Cash and cash equivalents$274,594  $296,871 
    Accounts receivable, net of allowance for doubtful accounts 65,015   56,754 
    Inventories, net 72,791   63,238 
    Prepaid expenses 5,768   7,615 
    Other current assets 3,126   2,841 
    Total Current Assets 421,294   427,319 
    Property, plant and equipment, net 1,039,980   979,164 
    Deposits on equipment 1,118   1,895 
    Operating lease right of use assets 3,671   3,616 
    Long term investment in equity securities 33,446   23,528 
    Other assets 32,189   28,899 
    Total Assets$1,531,698  $1,464,421 
    LIABILITIES AND STOCKHOLDERS' EQUITY   
    CURRENT LIABILITIES:   
    Accounts payable$35,481  $36,096 
    Accrued expenses 50,396   49,816 
    Current operating lease liabilities 1,290   1,312 
    Current finance lease liabilities 2,075   1,998 
    Total Current Liabilities$89,242  $89,222 
    Convertible senior notes 394,633   393,074 
    Long term operating lease liabilities 2,556   2,591 
    Long term finance lease liabilities 23,820   26,080 
    Total Liabilities$510,251  $510,967 
    Commitments and contingencies     
    STOCKHOLDERS' EQUITY:   
    Common stock — voting, $0.001 par value, 200,000 shares authorized, 48,551 issued and 48,537 outstanding on September 30, 2024, and 48,277 issued and 48,263 outstanding on December 31, 2023 48   48 
    Additional paid-in capital 1,321,767   1,282,984 
    Accumulated deficit (299,928)  (328,731)
    Accumulated other comprehensive loss (184)  (591)
    Treasury stock, at cost — 14 shares on September 30, 2024 and on December 31, 2023 (256)  (256)
    Total Stockholders' Equity 1,021,447   953,454 
    Total Liabilities and Stockholders' Equity$1,531,698  $1,464,421 


    FRESHPET, INC. AND SUBSIDIARIES
    CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS)
    (Unaudited, in thousands, except per share data)
     
     For the Three Months Ended
    September 30,
     For the Nine Months Ended
    September 30,
      2024   2023   2024   2023 
    NET SALES$253,367  $200,621  $712,469  $551,474 
    COST OF GOODS SOLD 151,120   134,328   428,112   375,177 
    GROSS PROFIT 102,247   66,293   284,357   176,297 
    SELLING, GENERAL, AND ADMINISTRATIVE EXPENSES 90,338   73,371   265,734   221,638 
    INCOME (LOSS) FROM OPERATIONS 11,909   (7,078)  18,623   (45,341)
    OTHER INCOME (EXPENSES):       
    Interest and Other Income, net 2,963   4,130   9,158   9,185 
    Interest Expense (2,923)  (4,148)  (8,734)  (10,648)
    Gain on Equity Investment       9,918    
      40   (18)  10,342   (1,463)
    INCOME (LOSS) BEFORE INCOME TAXES 11,949   (7,096)  28,965   (46,804)
    INCOME TAX EXPENSE 54   70   162   210 
    LOSS ON EQUITY METHOD INVESTMENT          1,890 
    INCOME (LOSS) ATTRIBUTABLE TO COMMON STOCKHOLDERS$11,895  $(7,166) $28,803  $(48,904)
    OTHER COMPREHENSIVE INCOME (LOSS):       
    Change in foreign currency translation$604  $(296) $407  $(2,329)
    TOTAL OTHER COMPREHENSIVE INCOME (LOSS) 604   (296)  407   (2,329)
    TOTAL COMPREHENSIVE INCOME (LOSS)$12,499  $(7,462) $29,210  $(51,233)
    NET INCOME (LOSS) PER SHARE ATTRIBUTABLE TO COMMON STOCKHOLDERS       
    -BASIC$0.25  $(0.15) $0.59  $(1.02)
    -DILUTED$0.24  $(0.15) $0.57  $(1.02)
    WEIGHTED AVERAGE SHARES OF COMMON STOCK OUTSTANDING       
    -BASIC 48,509   48,194   48,436   48,123 
    -DILUTED 50,282   48,194   50,203   48,123 


    FRESHPET, INC. AND SUBSIDIARIES
    CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS
    (Unaudited, in thousands)
     
     For the Nine Months Ended
    September 30,
      2024   2023 
    CASH FLOWS FROM OPERATING ACTIVITIES:   
    Net income (loss)$28,803  $(48,904)
    Adjustments to reconcile net income (loss) to net cash flows provided by operating activities:   
    Provision for loss on accounts receivable 15   9 
    Loss on disposal of property, plant and equipment 1,054   688 
    Share-based compensation 37,862   24,952 
    Inventory obsolescence 732    
    Depreciation and amortization 52,249   45,436 
    Write-off and amortization of deferred financing costs and loan 1,559   3,548 
    Change in operating lease right of use asset 1,045   1,175 
    Loss on equity method investment    1,890 
    Gain on equity investment (9,918)   
    Changes in operating assets and liabilities:   
    Accounts receivable (8,294)  3,148 
    Inventories (8,852)  (773)
    Prepaid expenses and other current assets (803)  (696)
    Other assets (1,540)  (3,495)
    Accounts payable 8,839   2,300 
    Accrued expenses 2,355   11,109 
    Operating lease liability (1,187)  (1,419)
    Net cash flows provided by operating activities 103,919   38,968 
    CASH FLOWS FROM INVESTING ACTIVITIES:   
    Purchase of short-term investments    (113,441)
    Proceeds from maturities of short-term investments    113,441 
    Acquisitions of property, plant and equipment, software and deposits on equipment (128,828)  (161,642)
    Net cash flows used in investing activities (128,828)  (161,642)
    CASH FLOWS FROM FINANCING ACTIVITIES:   
    Proceeds from exercise of options to purchase common stock 5,516   4,172 
    Tax withholdings related to net shares settlements of restricted stock (1,440)  (859)
    Purchase of capped call options    (66,211)
    Proceeds from issuance of convertible senior notes    393,518 
    Debt issuance costs    (2,026)
    Principal payments under finance lease obligations (1,444)  (548)
    Net cash flows provided by financing activities 2,632   328,046 
    NET CHANGE IN CASH AND CASH EQUIVALENTS (22,277)  205,372 
    CASH AND CASH EQUIVALENTS, BEGINNING OF YEAR 296,871   132,735 
    CASH AND CASH EQUIVALENTS, END OF PERIOD$274,594  $338,107 


    FRESHPET, INC. AND SUBSIDIARIES
    RECONCILIATION BETWEEN GROSS PROFIT AND ADJUSTED GROSS PROFIT
     
     For the Three Months Ended
    September 30,
     For the Nine Months Ended
    September 30,
      2024   2023   2024   2023 
            
     (Dollars in thousands)
    Gross profit$102,247  $66,293  $284,357  $176,297 
    Depreciation expense 13,197   11,767   35,698   33,106 
    Non-cash share-based compensation 1,610   2,579   6,451   8,696 
    Loss on disposal of manufacturing equipment 639      692    
    Adjusted Gross Profit$117,693  $80,639  $327,198  $218,099 
    Adjusted Gross Profit as a % of Net Sales 46.5%  40.2%  45.9%  39.5%


    FRESHPET, INC. AND SUBSIDIARIES
    RECONCILIATION BETWEEN SG&A EXPENSES AND ADJUSTED SG&A EXPENSES
     
     For the Three Months Ended
    September 30,
     For the Nine Months Ended
    September 30,
      2024   2023   2024   2023 
            
     (Dollars in thousands)
    SG&A expenses$90,338  $73,371  $265,734  $221,638 
    Depreciation and amortization expense 5,512   4,452   15,967   12,043 
    Non-cash share-based compensation (a) 10,498   5,511   31,411   16,256 
    Loss on disposal of equipment 129   226   362   688 
    Enterprise Resource Planning (b)    212      1,550 
    Capped Call Transactions fees (c)          113 
    Shareholder activism defense engagement (d)    5,548      8,177 
    Organization changes (e)          (67)
    Adjusted SG&A Expenses$74,199  $57,422  $217,994  $182,878 
    Adjusted SG&A Expenses as a % of Net Sales 29.3%  28.6%  30.6%  33.2%


    (a)Includes true-ups to share-based compensation expense compared to prior periods. We have certain outstanding share-based awards with performance-based vesting conditions that require the achievement of certain Adjusted EBITDA and/or Net Sales targets as a condition of vesting. At each reporting period, we reassess the probability of achieving the performance criteria and the performance period required to meet those targets. When the probability of achieving such performance conditions changes, the compensation cost previously recorded is adjusted as needed. When such performance conditions are deemed to be improbable of achievement, the compensation cost previously recorded is reversed.
    (b)Represents costs associated with the implementation of an ERP system.
    (c)Represents fees associated with the Capped Call Transactions.
    (d)Represents advisory fees related to shareholder activism defense engagement.
    (e)Represents a true-up to transition costs related to the organization changes designed to support growth, including several changes in organizational structure designed to enhance capabilities and support long-term growth objectives.


     
    FRESHPET, INC. AND SUBSIDIARIES
    RECONCILIATION BETWEEN NET INCOME (LOSS) AND ADJUSTED EBITDA
     
     For the Three Months Ended
    September 30,
     For the Nine Months Ended
    September 30,
      2024   2023   2024   2023 
            
     (Dollars in thousands)
    Net income (loss)$11,895  $(7,166) $28,803  $(48,904)
    Depreciation and amortization 18,709   16,219   51,665   45,149 
    Interest income, net of interest expense (40)  18   (424)  1,463 
    Income tax expense 54   70   162   210 
    EBITDA 30,618   9,141   80,206   (2,082)
    Loss on equity method investment          1,890 
    Gain on equity investment       (9,918)   
    Loss on disposal of property, plant and equipment 768   226   1,054   688 
    Non-cash share-based compensation (a) 12,108   8,090   37,862   24,952 
    Enterprise Resource Planning (b)    212      1,550 
    Capped Call Transactions fees (c)          113 
    Shareholder activism defense engagement (d)    5,548      8,177 
    Organization changes (e)          (67)
    Adjusted EBITDA$43,494  $23,217  $109,204  $35,221 
    Adjusted EBITDA as a % of Net Sales 17.2%  11.6%  15.3%  6.4%


    (a)Includes true-ups to share-based compensation expense compared to prior periods. We have certain outstanding share-based awards with performance-based vesting conditions that require the achievement of certain Adjusted EBITDA and/or Net Sales targets as a condition of vesting. At each reporting period, we reassess the probability of achieving the performance criteria and the performance period required to meet those targets. When the probability of achieving such performance conditions changes, the compensation cost previously recorded is adjusted as needed. When such performance conditions are deemed to be improbable of achievement, the compensation cost previously recorded is reversed.
    (b)Represents costs associated with the implementation of an ERP system.
    (c)Represents fees associated with the Capped Call Transactions.
    (d)Represents advisory fees related to shareholder activism defense engagement.
    (e)Represents a true-up to transition costs related to the organization changes designed to support growth, including several changes in organizational structure designed to enhance capabilities and support long-term growth objectives.



    Primary Logo

Опубликовать